Professors Jin Yan and Ai Hua to Share Insights at the Regenerative Biomaterials Forum during the 8th VBEF Future Healthcare Ecosystem Expo

Bio-regenerative materials, which emerged in the early 20th century, have now become a frontier and key area of development in materials science, biotechnology, and clinical medicine, as well as the foundation of the entire biomedical engineering field, driven by growing demand across multiple sectors and continuous technological advancements. They have also become one of the most dynamic industries within the economic system.

Leveraging cutting-edge technologies such as 3D printing, biosensing, and neuro-optoelectronics, bio-regenerative materials are not only undergoing continuous transformation and upgrading but also expanding the boundaries of clinical applications. On a positive note, driven by strong national policy support and sustained, stable demand from the upstream industry, bio-regenerative materials boast broad development prospects. However, in the process of translating innovative technologies into clinical applications, they still face industrialization challenges related to biocompatibility, durability, stability, and production costs.

From May 7 to 10, 2024, the 8th Future Healthcare Ecosystem Expo, themed “New Youth,” will be grandly held at the Beijing·Beiren Yichuang International Convention and Exhibition Center. The event is organized by VB100, VCBeat, Eggshell Research Institute, and VBDATA, co-organized by the Tianjin Economic-Technological Development Area (TEDA), and conducted in strategic cooperation with the Management Committee of Tianjin Binhai Zhongguancun Science Park and Beitang Bay Digital Economy Industrial Park. As one of the popular forum sessions, the Biomaterials Regeneration Forum will take place on the afternoon of May 10. This forum brings together cross-sector partners from government, industry, academia, research, healthcare, and investment communities, jointly committed to advancing the translation and clinical implementation of regenerative biomaterials.

This Bio-Regenerative Materials Forum is packed with highlights. It not only facilitates exchange, collaboration, and advocacy among stakeholders in the bio-regenerative materials industry, but also delves into the pressing contemporary challenges of innovative translation and clinical implementation of bio-regenerative materials. Moreover, it features the highly anticipated premiere of VCBeat’s “2024 Bio-Regenerative Materials Industry Research Report.”

Specifically, the forum has invitedChief Scientist of the Key Projects of the Ministry of Science and Technology, Chang Jiang Scholar Distinguished Professor, recipient of the National Science Fund for Distinguished Young Scholars, and Founder of the Tissue Engineering Research and Development Center at Air Force Medical University;Featuring experts such as professors and doctoral supervisors from the National Engineering Research Center for Biomaterials at Sichuan University, as well as Fellows of the American Institute for Medical and Biological Engineering, this event brings together scientist-founders from China’s leading companies specializing in the application of frontier bio-regenerative material technologies and their clinical translation. Together with CDMO service providers in the biomaterials sector and key players across the bio-regenerative materials industry chain, they will jointly explore the challenges and breakthrough strategies for the innovative translation and clinical implementation of bio-regenerative materials.

The forum features two main segments: “Keynote Speeches” and “Roundtable Discussions.” In the Keynote Speeches segment, experts will share insights on cutting-edge topics such as the opportunities and challenges in bio-regenerative materials, as well as development strategies and translational applications of cell-based regenerative medicine in niche sectors. VCBeat will premiere its *2024 Industry Research Report on Bio-Regenerative Materials: A Key Branch of Regenerative Medicine, with Innovation Led by Orthopedics, Trauma, and Medical Aesthetics*, clarifying the developmental trajectory of the bio-regenerative materials industry. Corporate representatives will discuss topics including the application of frontier technologies (such as 3D printing), clinical translation of tissue repair functions, and diversified innovations in bio-regenerative materials, drawing from their practical experience and industry development needs. During the Roundtable Discussions, representatives from industry, academia, research institutions, and investment sectors will engage in in-depth discussions on key aspects of innovative translation and clinical implementation of bio-regenerative materials, addressing bottlenecks in translation and future development trends.

Currently, the forum has invited the following renowned experts, leading representative enterprises, and representatives from investment institutions to participate:

1. Jin Yan, Chief Scientist of the Ministry of Science and Technology’s “973 Program” and Key Projects, Changjiang Scholar Distinguished Professor, Recipient of the National Science Fund for Distinguished Young Scholars, and Founder of the Tissue Engineering Research and Development Center at Air Force Medical University

2. IVAi Hua, Professor and Doctoral Supervisor at the National Engineering Research Center for Biomaterials of Sichuan University, Fellow of the American Institute for Medical and Biological Engineering

3. Jiao Yanli, Senior Researcher at VCBeat

4. Yang Xi, Co-founder and CEO of Nuopu Regenerative Medicine

5. Li Qiang, SFM Division, Aotai Kang

6. Sun Lin, Founder & Chairman of Saidikang

7. Jiang Fangfang, Investment Director at Daoyuan Capital

……

The excellent tissue compatibility of bio-regenerative materials endows them with the capacity to replace, repair, and regenerate living tissues and organs, facilitating their application across multiple fields such as orthopedics, trauma repair, cosmetology, and skincare. Today, biomaterials are widely used in clinical practice, with related products accounting for approximately 40%–50% of the medical device market. The unstoppable rise of bio-regenerative materials is already underway; what new opportunities will their innovative translation and clinical implementation create? This May, the 8th Future Medical Ecology Fair (VBEF) will be held in Beijing, the forefront of China’s medical development. We invite you to join us as we gather senior industry experts, leading enterprises, and innovative products and services!

Registration Now Open for the Bio-Regenerative Materials Forum Audience: Scan the QR Code and Reply “Sub-Forum” to Get a Free Ticket.